Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Open Label Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)

NCT07671157 is registered in ClinicalTrials.gov with Maryanne Makredes Senna as lead sponsor.

NCT NCT07671157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07671157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Open Label Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)
Lead sponsor
Maryanne Makredes Senna
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 10, 2026
Completion date
October 10, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frontal fibrosing alopecia